Objectives: This study is aimed at analyzing genetic polymorphisms of NAT2, CYP2E1, and GSTM1 genes in Saudi TB patients, monitoring INH drug levels, and exploring correlations between these genetic variations, drug levels, hepatotoxicity incidence, and clinical outcomes. This evidence concerns the gene CYP2E1 and tuberculosis.